38 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
requiring establishment and maintenance of effective disclosure and financial controls, changes in corporate governance practices, proxy access and “say … . Directors, Executive Officers and Corporate Governance
Information required by this item will be contained in our definitive proxy statement to be filed
424B4
ggr8j7dlo3hfo4ruc
9 Feb 24
Prospectus supplement with pricing info
5:14pm
PRE 14A
7mfx23cg
12 Mar 21
Preliminary proxy
8:30am